The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach

JM Bos, E (Edwin) Rietveld, Henriette Moll, Ewout Steyerberg, W Luytjes, Janneke Wilschut, Ronald Groot, MJ Postma

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)6922-6929
Number of pages8
JournalVaccine
Volume25
DOIs
Publication statusPublished - 2007

Cite this